Question

Difficulty: Very hardPharmacological and Parenteral Therapies

A nurse is caring for an 80 kg80\text{ kg} adult client experiencing status epilepticus. The healthcare provider prescribes a loading dose of intravenous (IV) phenytoin at 15 mg/kg15\text{ mg/kg}. The client currently has a continuous infusion of 5% dextrose in water (D5W)5\%\text{ dextrose in water (D5W)} running at 50 mL/hr50\text{ mL/hr} via a 22-gauge peripheral IV catheter in the right dorsal hand. Based on the pharmacological properties of phenytoin, which of the following is the most appropriate action by the nurse?

  1. A
    Prioritize rapid termination of the seizure by administering the medication undiluted via IV push over 5 minutes to quickly achieve therapeutic serum levels.
  2. B
    Dilute the medication in 250 mL250\text{ mL} of 5% dextrose in water (D5W)5\%\text{ dextrose in water (D5W)} and administer via a secondary infusion over 45 minutes.
  3. Establish a new 18-gauge IV access in a large proximal vein, dilute the dose in 0.9% sodium chloride0.9\%\text{ sodium chloride}, and infuse over at least 30 minutes.Answer
  4. D
    Pause the D5W infusion, flush the existing 22-gauge IV catheter with 0.9% sodium chloride0.9\%\text{ sodium chloride}, and administer the dose via IV push over 15 minutes.

Answer

Establish a new 18-gauge IV access in a large proximal vein, dilute the dose in 0.9% sodium chloride0.9\%\text{ sodium chloride}, and infuse over at least 30 minutes.
Intravenous phenytoin requires strict adherence to multiple safety parameters. The total dose is 1200 mg1200\text{ mg} (80 kg×15 mg/kg80\text{ kg} \times 15\text{ mg/kg}). Because the maximum safe administration rate is 50 mg/min50\text{ mg/min}, the absolute minimum infusion time is 24 minutes. Infusing over 30 minutes achieves a safe rate of 40 mg/min40\text{ mg/min}. Furthermore, phenytoin precipitates in dextrose and requires dilution in 0.9% sodium chloride0.9\%\text{ sodium chloride}. Because it is a known vesicant that can cause 'purple glove syndrome' (severe localized ischemia and edema), it must be administered through a large-bore catheter (18- or 20-gauge) in a large proximal vein, avoiding small distal veins like those in the hand.

Step-by-Step Solution

1
Calculate the total required dose based on the client's weight.
80 kg×15 mg/kg=1200 mg80\text{ kg} \times 15\text{ mg/kg} = 1200\text{ mg} of phenytoin.
Accurate weight-based dosing is critical for determining the total medication volume and subsequent infusion parameters.
2
Determine the minimum safe infusion time based on the maximum allowable rate.
1200 mg÷50 mg/min=24 minutes1200\text{ mg} \div 50\text{ mg/min} = 24\text{ minutes}.
Phenytoin has a strict maximum administration rate of 50 mg/min50\text{ mg/min} in adults to prevent severe hypotension and lethal dysrhythmias.
3
Evaluate the current IV access and fluid compatibility.
The current 22-gauge IV is too small for a vesicant, and the continuous D5W infusion is incompatible with phenytoin.
Phenytoin precipitates in dextrose and is highly irritating to veins, risking purple glove syndrome if given in small distal veins.
4
Select the intervention that meets all safety criteria: dose rate, compatibility, and vascular access.
Inserting a new 18-gauge IV in a large vein, diluting with normal saline, and infusing over 30 minutes (40 mg/min40\text{ mg/min}) is the only completely safe option.
This comprehensively addresses the pharmacological constraints and safety requirements for IV phenytoin administration.

Key Concept

Safe administration of intravenous phenytoin requires synthesis of weight-based dosing, rate calculation (max 50 mg/min50\text{ mg/min}), fluid compatibility (only 0.9% NaCl0.9\%\text{ NaCl}), and vesicant precautions.
Rate this question